Opiant   Report issue

For profit Phase 1 Phase 3
Founded: Santa Monica CA United States (2009)
Status: No NME R&D (2009)

Organization Overview

First Clinical Trial
2011
NCT01567670
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Opiant Pharmaceuticals Inc